Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers

被引:129
作者
Zhu, JM
Tang, AG
Law, LP
Feng, M
Ho, KM
Lee, DKL
Harris, FW
Li, P [1 ]
机构
[1] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Polytech Univ, Open Lab Chirotechnol, Inst Mol Technol Drug Discovery & Synth, Kowloon, Hong Kong, Peoples R China
[3] Univ Akron, Maurice Morton Inst Polymer Sci, Akron, OH 44325 USA
关键词
D O I
10.1021/bc049895l
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Spherical, well-defined core-shell nanoparticles that consist of poly(methyl methacrylate) (PMMA) cores and branched poly(ethylenimine) shells (PEI) were synthesized via a graft copolymerization of methyl methacrylate from branched PEI induced by a small amount of tert-butyl hydroperoxide. The PMMA-PEI core-shell nanoparticles were between 130 to 170 nm in diameter and displayed zeta-potentials near +40 mV at pH 7 in 1 mM aqueous NaCl. Plasmid DNA (pDNA) was mixed with nanoparticles and formed complexes of approximately 120 nm in diameter and was highly monodispersed. The complexes were characterized with respect to their particle size, zeta-potential, surface morphology, and DNA integrity. The complexing ability of the nanoparticles was strongly dependent on the molecular weight of the PEI and the thickness of the PEI shells. The stability of the complexes was influenced by the loading ratio of the pDNA and the nanoparticles. The condensed pDNA in the complexes was significantly protected from enzymatic degradation by DNase I. Cytotoxity studies using MTT colorimetric assays suggested that the PMMA-PEI (25 kDa) core-shell nanoparticles were three times less toxic than the branched PEI (25 kDa). Their transfection efficiencies were also significantly higher. Thus, the PEI-based core-shell nanoparticles show considerable potential as carriers for gene delivery.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 22 条
[1]   Synthesis of linear polyethylenimine derivatives for DNA transfection [J].
Brissault, B ;
Kichler, A ;
Guis, C ;
Leborgne, C ;
Danos, O ;
Cheradame, H .
BIOCONJUGATE CHEMISTRY, 2003, 14 (03) :581-587
[2]   The future of gene therapy [J].
Cavazzana-Calvo, M ;
Thrasher, A ;
Mavilio, F .
NATURE, 2004, 427 (6977) :779-781
[3]   IN-VITRO CYTOTOXICITY OF MACROMOLECULES IN DIFFERENT CELL-CULTURE SYSTEMS [J].
CHOKSAKULNIMITR, S ;
MASUDA, S ;
TOKUDA, H ;
TAKAKURA, Y ;
HASHIDA, M .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) :233-241
[4]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[5]  
ERACHER P, 1995, BIOCONJUGATE CHEM, V6, P401
[6]   A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine:: Effect of molecular weight on transfection efficiency and cytotoxicity [J].
Fischer, D ;
Bieber, T ;
Li, YX ;
Elsässer, HP ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 1999, 16 (08) :1273-1279
[7]  
Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO
[8]  
2-Q
[9]   Poly(ethylenimine) and its role in gene delivery [J].
Godbey, WT ;
Wu, KK ;
Mikos, AG .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :149-160
[10]   Design and gene delivery activity of modified polyethylenimines [J].
Kircheis, R ;
Wightman, L ;
Wagner, E .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 53 (03) :341-358